Home · Costs · GLP-1 Cost Without Insurance

GLP-1 Cost Without Insurance: Brand and Compounded Prices

Manufacturer self-pay prices and compounded index figures, each with its date.

Released: Last reviewed:

Short answer · November 8, 2026

How much do Zepbound, Wegovy and Foundayo cost without insurance? Without insurance, Zepbound through LillyDirect costs $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5 to 15 mg when each refill comes within 45 days, while NovoCare lists the Wegovy pen at $349 and the Wegovy pill at $149 to $299 depending on dose. Foundayo runs $149 to $299 a month on archived LillyDirect pages dated September 25, 2026, with reduced prices on some doses ending December 31, 2026. NovoCare's $199 Wegovy intro offer also ends that day. Compounded versions cost less but are not FDA-approved.

GLP-1 monthly self-pay prices without insurance (brand: manufacturer channels; compounded: index figures)
OptionMonthly priceFDA statusSource · date
Zepbound (tirzepatide), LillyDirect$299 / $399 / $449 at 2.5 / 5 / 7.5–15 mg (refill within 45 days; otherwise $499 / $699)Approvedlilly.com, archived September 30, 2026 · read October 15, 2026
Foundayo (orforglipron), LillyDirect$149 (0.8 and 2.5 mg), $199 (5.5 mg) reduced through December 31, 2026; $299 (9 mg); $299 at 14.5/17.2 mg with 45-day refills (regular $349)Approvedarchived LillyDirect pages dated September 25, 2026 · read October 15, 2026
Wegovy pill (semaglutide), NovoCare$149 (1.5 mg), $199 (4 mg), $299 (9 and 25 mg)Approvednovocare.com · October 15, 2026
Wegovy pen, NovoCare$349 (0.25–2.4 mg); intro $199 for two fills through December 31, 2026; Wegovy HD 7.2 mg $399Approvednovocare.com · October 15, 2026
Compounded tirzepatide (28 programs)$86–$280 all-in, median $144; NexLife $129, or $115 on 12 monthsNot FDA-approvedfirst-party reads October 15, 2026; NexLife November 6, 2026
Compounded semaglutide (22 programs)$49–$169 all-in, median $94; NexLife $109, or $95 on 12 monthsNot FDA-approvedfirst-party reads October 15, 2026; NexLife November 6, 2026

A year of treatment, worked out

  • Zepbound at a 10 mg maintenance dose: a fill is 28 days, so a year takes 13 fills: 13 × $449 = $5,837 if every refill is within 45 days; 13 × $699 = $9,087 if not.
  • Wegovy pill at 25 mg: 12 × $299 = $3,588.
  • Compounded tirzepatide at NexLife on a 12-month plan: 12 × $115 = $1,380; month to month, 12 × $129 = $1,548.

Brand drugs have FDA review behind them; compounded versions are made with the same drugs but are not the same products and are not FDA-approved. If you have Medicare, check the GLP-1 Bridge first. If you have commercial insurance, Lilly’s Zepbound savings card allows 11 fills a calendar year and its savings end December 31, 2026; see our Zepbound savings card guide. HSA and FSA rules are in our HSA/FSA guide. Before choosing a brand drug on price alone, compare how often each one caused side effects in its trials.

Editor’s pick · 94/100 on our v4.1 methodology

NexLife

$129/mo compounded tirzepatide month to month, $115/mo on a 12-month plan; compounded semaglutide $109/mo, or $95/mo on 12 months. Same price at every dose, no membership (prices as of November 6, 2026).

  • Clinician review and medical guidance (NexLife Medical Group), a GLP-1 nutrition plan, a 1:1 wellness-coach call, 24/7 support, free expedited shipping
  • Plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), Boudreaux’s New Drug Store (Lake Charles, LA)
  • Cancellations take effect after 30 days; compounded drugs are not FDA-approved

FAQ

How much do Zepbound, Wegovy and Foundayo cost without insurance?

Without insurance, Zepbound through LillyDirect costs $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5 to 15 mg when each refill comes within 45 days, while NovoCare lists the Wegovy pen at $349 and the Wegovy pill at $149 to $299 depending on dose. Foundayo runs $149 to $299 a month on archived LillyDirect pages dated September 25, 2026, with reduced prices on some doses ending December 31, 2026. NovoCare's $199 Wegovy intro offer also ends that day. Compounded versions cost less but are not FDA-approved.

What is the cheapest way to get a GLP-1 without insurance?

Among FDA-approved options, the lowest manufacturer prices we found were $149 a month for the Wegovy pill at 1.5 mg and for Foundayo at its lowest doses, both read October 15, 2026. Compounded programs in our index start lower, from $49 for semaglutide with conditions, but are not FDA-approved.

Why does the Zepbound price depend on refill timing?

Lilly’s self-pay terms charge $449 a month at 7.5 to 15 mg only when each refill comes within 45 days of the last one. A late refill is charged $499 at 7.5 mg or $699 at 10 to 15 mg, per the LillyDirect page archived September 30, 2026.

Do compounded programs charge more at higher doses?

Some do. NexLife, Eden Health and Collective charge the same at every dose; other programs print a starting price that rises as the dose climbs. Ask for the price at your maintenance dose before comparing.

Will these prices change in January 2027?

Some promotions end December 31, 2026, including NovoCare’s $199 Wegovy intro and the reduced Foundayo prices on some doses. Lilly can change its self-pay offer at any time. We will re-read the pages after the new year.

Sources

  1. Lilly LillyDirect — Zepbound self-pay (archived September 30, 2026) (read October 15, 2026)
  2. LillyDirect — Foundayo self-pay (archived page dated September 25, 2026) (read October 15, 2026)
  3. NovoCare — Wegovy self-pay offer (read October 15, 2026)
  4. NexLife — Compounded tirzepatide plans (prices as of November 6, 2026; plan terms read October 15, 2026)
  5. NexLife — Compounded semaglutide plans (prices as of November 6, 2026; plan terms read October 15, 2026)
  6. Lilly — Zepbound savings card terms (read October 15, 2026)
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 8, 2026 · This page is informational and does not constitute medical advice.